Unrated Drug recall · FDA · Published January 28, 2020

Kushim Tablets (Gush: 45-count packages with foreign language label - FDA recall

FDA recalls Kushim Tablets (Gushim) 45-count packages with foreign language labels due to unapproved ingredients. These products contain cinobufagin, bufalin, and bufotenine without FDA approval.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0840-2020Drug B AND A TRADING CORPORATION ›

Recall notice

Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine

Take action

Contact the company

Recalling firmB AND A TRADING CORPORATION325 Washington Ave · Carlstadt, NJ 07072-2805

✎ GovInfoNow plain-language explainer

The FDA has recalled Kushim Tablets (Gushim) 45-count packages that have labels in a foreign language. These products contain unapproved ingredients that could pose health risks. Read more at govinfonow.com/recall/37394-kushim-tablets-gush-45-count-packages-with-foreign-language-label.

Source Summary by GovInfoNow · govinfonow.com/recall/37394-kushim-tablets-gush-45-count-packages-with-foreign-language-label · Updated October 5, 2026 · FDA enforcement record: FDA #D-0840-2020

Cite this page

“Kushim Tablets (Gush: 45-count packages with foreign language label - FDA recall.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37394-kushim-tablets-gush-45-count-packages-with-foreign-language-label. Based on FDA recall #D-0840-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0840-2020%22&limit=1).

B and A Trading Corporation recalled Kushim Tablets (Gushim) 45-count packages with foreign language labels due to undeclared ingredients, the FDA said on Jan. 28, 2020. The product contains cinobufagin, bufalin, and bufotenine.

How to tell if you have it

Brand: B AND A TRADING CORPORATION
Product: Kushim Tablets (Gushim)
Size: 45-count packages
Lot #: H003
Distribution: NY & NJ only
Quantity: 40 packages

The hazard

The FDA classified the recall as Class II because the tablets were marketed without an approved New Drug Application or Abbreviated New Drug Application. Analysis found the product to contain cinobufagin, bufalin, and bufotenine.

Context

GovInfoNow's records show other recent recalls of similar products include Golden State Baclofen Tablets Recall: Foreign Tablets Risk (2025-11-26), Buy-Herbal Kian Pee Wan Capsules Recall: Undeclared Drug Ingredients (2026-03-21), and Shoolin Pharma Chem Tadalafil Recall: FDA Inspection Findings (2026-08-03).

How to tell if you have this one

Check for Kushim Tablets (Gushim) 45-count packages with labels in a foreign language. The specific lot number H003 is associated with this recall.

Brand
B AND A TRADING CORPORATION
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Label
Look for a foreign language label on the 45-count package of Kushim Tablets (Gushim).

Where it went and when

Where it was distributed

Distributed in New Jersey and New York.

FDA distribution: “NY & NJ only” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Jersey, New York.

Recall timeline

FDA terminated this recall 3.9 years after the firm started it.

Jan 28, 2020Firm started the recall
Feb 12, 2020FDA classified it Class II
Feb 19, 2020Published in FDA’s Enforcement Report
Dec 21, 2023FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/37394-kushim-tablets-gush-45-count-packages-with-foreign-language-label">Kushim Tablets (Gush: 45-count packages with foreign language label - FDA recall (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0840-2020 (January 28, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0840-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.